Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

Summary

Meet our team and listen to our sponsored talk by Reinhold Horlacher, PhD, from trenzyme, on Wednesday, 11 November at 12:35 CET.

Our team

Talk: High-Yield Production of SARS-CoV-2 Proteins: From Small Scale Transfection to GMP Compliant Process.

To support research groups for development of serological tests, generation of high-affinity antibodies and new vaccine candidates, trenzyme has developed a platform for rapid production of high-quality recombinant SARS-CoV-2 proteins by transient transfection, high-producer cell lines and even GMP compliant production cell lines for development of the intranasal vaccine XPOVAX.

Presented by Reinhold Horlacher, PhD, Managing Director at trenzyme.

Wednesday, 11 November at 12:35 CET.

 

General information

Registration link for virtual event: click here